Abstract
We have synthesized a series of short peptides (17 to 20 amino acids), originally derived from Limulus antilipopolysaccharide factor LALF, which were primarily designed to act as antimicrobial agents as well as neutralizers of bacterial endotoxin (lipopolysaccharide, LPS), Here, two selected peptides, a 17- and a 19-mer, were characterized physicochemically and in biological test systems. The secondary structure of the peptides indicates essentially a β-sheet including antiparallel strands, the latter being reduced when the peptides bind to LPS. A very strong exothermic binding due to attractive Coulomb interactions governs the LPS-peptide reaction, which additionally leads to a fluidization of the acyl chains of LPS. A comparison of the interaction of the peptide with negatively charged phosphatidylserine shows in contrast a rigidification of the acyl chains of the lipid. Finally, the biological assays reveal a diverging behaviour of the two peptides, with higher antibacterial activity of the 17-mer, but a much higher activity of the 19-mer in its ability to inhibit the LPS-induced cytokine production in human mononuclear cells.
Keywords: Sepsis, antimicrobial peptides, LPS, MIC, isothermal titration calorimetry, isothermal, Lipid, LALF, (AMPs), Gram-negative bacteria, AEP, RP-HPLC, (DMPS), HEPES buffer, (ITC), FTIR Spectroscopy, (MIC), (MNC), ELISA, (PS), (TNF)
Protein & Peptide Letters
Title: Physicochemical and Biological Characterization of Anti-Endotoxin Peptides and Their Influence on Lipid Properties
Volume: 17 Issue: 11
Author(s): Ina Kowalski, Yani Kaconis, Jorg Andra, Iosu Razquin-Olazaran, Thomas Gutsmann, Guillermo Martinez de Tejada and Klaus Brandenburg
Affiliation:
Keywords: Sepsis, antimicrobial peptides, LPS, MIC, isothermal titration calorimetry, isothermal, Lipid, LALF, (AMPs), Gram-negative bacteria, AEP, RP-HPLC, (DMPS), HEPES buffer, (ITC), FTIR Spectroscopy, (MIC), (MNC), ELISA, (PS), (TNF)
Abstract: We have synthesized a series of short peptides (17 to 20 amino acids), originally derived from Limulus antilipopolysaccharide factor LALF, which were primarily designed to act as antimicrobial agents as well as neutralizers of bacterial endotoxin (lipopolysaccharide, LPS), Here, two selected peptides, a 17- and a 19-mer, were characterized physicochemically and in biological test systems. The secondary structure of the peptides indicates essentially a β-sheet including antiparallel strands, the latter being reduced when the peptides bind to LPS. A very strong exothermic binding due to attractive Coulomb interactions governs the LPS-peptide reaction, which additionally leads to a fluidization of the acyl chains of LPS. A comparison of the interaction of the peptide with negatively charged phosphatidylserine shows in contrast a rigidification of the acyl chains of the lipid. Finally, the biological assays reveal a diverging behaviour of the two peptides, with higher antibacterial activity of the 17-mer, but a much higher activity of the 19-mer in its ability to inhibit the LPS-induced cytokine production in human mononuclear cells.
Export Options
About this article
Cite this article as:
Kowalski Ina, Kaconis Yani, Andra Jorg, Razquin-Olazaran Iosu, Gutsmann Thomas, Martinez de Tejada Guillermo and Brandenburg Klaus, Physicochemical and Biological Characterization of Anti-Endotoxin Peptides and Their Influence on Lipid Properties, Protein & Peptide Letters 2010; 17 (11) . https://dx.doi.org/10.2174/0929866511009011328
DOI https://dx.doi.org/10.2174/0929866511009011328 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Microbial / Enzymatic Synthesis of Chiral Intermediates for Pharmaceuticals: Case Studies from BMS
Current Organic Chemistry The Basic Mechanism of Hair Growth Stimulation by Adipose-derived Stem Cells and Their Secretory Factors
Current Stem Cell Research & Therapy Editorial A New Year of Excellence
Current Molecular Medicine Clinical Application of Ghrelin
Current Pharmaceutical Design Mechanisms and Drug Targets for Pancreatic Cancer Chemoprevention
Current Medicinal Chemistry Towards More Successful Gene Therapy Clinical Trials for β-Thalassemia
Current Molecular Medicine Stem Cells in Kidney Regeneration
Current Medicinal Chemistry Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
Current Cancer Drug Targets Neuroinflammation: Microglial Activation During Sepsis
Current Neurovascular Research Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches
CNS & Neurological Disorders - Drug Targets Airway Obstruction in a Cancer Patient: Is it Always Cancer?
Current Respiratory Medicine Reviews Vitamin A in Prevention of Bronchopulmonary Dysplasia
Current Pharmaceutical Design Dogs with Cognitive Dysfunction Syndrome: A Natural Model of Alzheimer’s Disease
Current Alzheimer Research Biological Activity of Cytokines: An Evolutionary Perspective
Current Pharmaceutical Design An Updated Review on <i>Betacoronavirus</i> Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery
Current Topics in Medicinal Chemistry Alzheimer’s and Type 2 Diabetes Treatment via Common Enzyme Targeting
CNS & Neurological Disorders - Drug Targets Biology-Oriented Synthesis (BIOS) of Piperine Derivatives and their Comparative Analgesic and Antiinflammatory Activities
Medicinal Chemistry Substance P and its Inhibition in Ocular Inflammation
Current Drug Targets